RxDoctor Payments Data

Erin Kevern, DO

Otolaryngology · Elkhart, INNPI 1902245194

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Smith+Nephew at 57.3% of the total. Reporting peaked in 2021 at $10,566 and has fallen 88.3% since, to $1,238 in 2025. Among otolaryngology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,147in general payments, 2019–2025

Across 157 payments — averaging $166.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$15K
  • Inspire Medical Systems, Inc.$4K
  • Medtronic$3K
  • Stryker$2K
  • Aerin Medical Inc.$1K
  • Acclarent, Inc$587
  • plus $1K from 11 others

What the payments were for

  • Speaking & faculty fees$12,50048%
  • Travel & lodging$3,77314%
  • Food & beverage$9,87438%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,147 in reported general payments places this provider in the 95th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$44,923
Medicare patients
148
Services billed
447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$52,461
Ipratropium Bromide147$5,373
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth29$3,440
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip47$3,329
Omeprazole116$1,143
Fluticasone Propionate69$925
Ofloxacin28$650
Dexamethasone74$467
Montelukast Sodium13$348
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$191
Doxycycline Hyclate25$151
Mupirocin21$141
Pantoprazole Sodium11$103
Cefadroxil16$99
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$75

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Elkhart

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →